Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
about
Protein nanoparticles as drug delivery carriers for cancer therapyQuantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cellsNanocarriers Usage for Drug Delivery in Cancer TherapyRecent advancements in erythrocytes, platelets, and albumin as delivery systemsSystemic delivery to central nervous system by engineered PLGA nanoparticlesAlbumin-based drug delivery: harnessing nature to cure diseaseHypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?Bioabsorbable polymers in cancer therapy: latest developmentsFusion Proteins for Half-Life Extension of Biologics as a Strategy to Make BiobettersFuture of coagulation factor replacement therapyFatty acids as therapeutic auxiliaries for oral and parenteral formulationsCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Protease-resistant peptide design-empowering nature's fragile warriors against HIVGlycated albumin: an overview of the In Vitro models of an In Vivo potential disease markerPlasma proteins interaction with curcumin nanoparticles: implications in cancer therapeuticsCys34-PEGylated Human Serum Albumin for Drug Binding and DeliveryCXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.Development of macromolecular prodrug for rheumatoid arthritisStructural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albuminMacropinocytosis Exploitation by Cancers and Cancer TherapeuticsIn vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliverySimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapyProbing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albuminsTargeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imagingHuman serum albumin and p53-activating peptide fusion protein is able to promote apoptosis and deliver fatty acid-modified moleculesBSA nanoparticle loaded atorvastatin calcium--a new facet for an old drugThe effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancerDetermination of supplier-to-supplier and lot-to-lot variability in glycation of recombinant human serum albumin expressed in Oryza sativaAll-Purpose Containers? Lipid-Binding Protein - Drug InteractionsSynthetic nanoparticles of bovine serum albumin with entrapped salicylic acidDexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)Microemulsions for oral administration and their therapeutic applicationsNano/microparticles and ultrasound contrast agentsImaging lysosomal enzyme activity in live cells using self-quenched substrates.Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance-fluorescence imaging for tracking of chemotherapeutic agents.Combinatorial peptide libraries: mining for cell-binding peptides.Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trialSurvival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.
P2860
Q23923552-DE04B2AF-A1DB-43F1-B154-A5515A755A5FQ23923876-59843EE2-A481-4D05-A1CE-EDFDF2B5C8D5Q26740048-0CD78E96-D1D8-405C-8557-C0577C879753Q26747764-C4EE4316-0239-45F1-9F91-AC21DE278FC6Q26751294-638F047A-2CD5-4E88-9CB0-BBF7C1A20A56Q26765789-F90CA8D1-64AD-4C4B-BFDA-D098D776EC3DQ26771133-68F86B3D-5148-40BC-BD80-BB9D34ED072AQ26775714-86686315-B3E8-4935-8225-5D323D6B21ECQ26801319-1EBA81E9-B5B9-4E6D-AAAE-6E92914945E2Q26820824-BCBDF1AD-3B98-484C-87D9-B1469AD6E8DBQ26828805-0525EBF8-2E5F-4481-8CC0-93B5D22B2964Q26830028-BFCD735F-E076-4241-B504-8CA15FDCA278Q27010058-07FD5789-4DDC-48A8-AE11-E0B4642F9801Q27012452-5F6FEE4D-1D03-46D5-A40E-9EA5FACBDA64Q27026623-BE161A9F-95C2-49D3-815A-5FF89646A21CQ27301475-86CD6287-9F00-4508-B2CC-7846C52959F9Q27330200-095A9CCB-66B6-4D09-9429-33A84C6C934FQ27336445-C55F593F-6EF6-4200-B1A2-8E47971A89DBQ27693332-18AE0D67-A028-4FA2-A30C-B7B1982F101FQ27700781-1FF159D5-2A63-45B5-BC17-3D5ED4D59C5CQ28069487-02C0C55F-8DCE-4CB3-9D5A-07A31CCBB03AQ28396006-EE2600C0-B6A4-4F5C-AAE9-4DAFBDDA3575Q28397980-CA273766-8739-46C9-AC7E-17BA6F90D9E5Q28482550-6FCC8B6D-8EA0-4D10-AD29-87FEAB16AAE2Q28533782-9626DC8F-1752-48AE-93B4-12B32B87D751Q28535347-7737CBC7-0F66-4477-8215-958D1DCD51E9Q28539424-C3449691-E221-46F8-89C4-A56F593896BBQ28540889-F5BD2351-530C-4819-98D8-689A9434CDE7Q28543674-88770E83-1423-4EA6-A774-B73BF1AA4715Q28546452-9FE32B83-0536-4C0B-A581-8A6F3D3179A0Q28818198-4127981E-637B-44B1-8D9A-25FF32C8CC6CQ28829762-AFC02DDF-A992-4A2A-BD60-1DA02E4FF34BQ29307905-8E296746-40CB-4B33-AFC8-FE5B3726AE07Q30445347-8A89CEB5-5ED4-4357-AAC2-5BE18A70D1D5Q30513407-11482F29-22DB-4A63-BAA2-DF7738B73AE8Q30997634-E83B6CF9-AFA7-4E3A-8178-062573BF6D7BQ31127105-A229DD8C-C1A7-4231-AE43-DB9488FF1D76Q31144876-34A7B5C6-48AD-4D6C-95AB-F51FE241F2CEQ33410691-FAB1F43E-2C67-40AC-B740-3C54BEE4F9AFQ33423320-5C4903C9-D631-4D32-98D1-D1C21EF1D53E
P2860
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@en
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@nl
type
label
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@en
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@nl
prefLabel
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@en
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@nl
P1476
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
@en
P2093
Felix Kratz
P304
P356
10.1016/J.JCONREL.2008.05.010
P407
P577
2008-05-17T00:00:00Z